Fujinami-Yokokawa Yu

Laich Yannik, Georgiou Michalis, Fujinami Kaoru, Daich Varela Malena, Fujinami-Yokokawa Yu, Hashem Shaima Awadh et al.

This study analyzed Best vitelliform macular dystrophy (BVMD) with OCT and FAF, revealing diverse imaging phenotypes. Specific OCT features correlated with visual acuity, highlighting a slow, variable disease course, challenging therapeutic trial endpoint identification.

Katta Mohamed, de Guimaraes Thales A C, Fujinami-Yokokawa Yu, Fujinami Kaoru, Georgiou Michalis, Mahroo Omar A et al.

This study of 122 CSNB patients found stable retinal structure and visual acuity over time, with specific genetic variants (NYX, TRPM1) linked to myopia, aiding prognosis.

Fujinami-Yokokawa Yu, Joo Kwangsic, Liu Xiao, Tsunoda Kazushige, Kondo Mineo, Ahn Seong Joon et al.

This study found two RP1L1 gene hotspots cause distinct Miyake disease phenotypes: p.R45W leads to earlier, more severe vision loss, while 1196-1201aa causes a milder form, aiding prognosis and treatment.

Ahn Seong Joon, Yang Lizhu, Tsunoda Kazushige, Kondo Mineo, Fujinami-Yokokawa Yu, Nakamura Natsuko et al.

This study found central scotoma is the most common and severe visual field defect in East Asian occult macular dystrophy patients, correlating with worse vision, structural damage, and specific genotypes, aiding diagnosis and prognosis.